Skip to main content
. 2022 Oct 27;23(12):e13803. doi: 10.1002/acm2.13803

TABLE 1.

Percent mean dose differences from the RPA plan for selected contours from three anatomical sites

Site/contour RayStation‐CCC mean (LCL, UCL) a Eclipse‐Acuros mean (LCL, UCL) a
Head and neck
Brain −0.21 (−0.44, 0.01) −0.24 (−0.42, −0.05)
CTV1 2.19 (1.04, 3.34) −0.25 (−1.25, 0.75)
CTV2 1.26 (0.11, 2.40) −0.22 (−0.72, 0.28)
CTV3 1.11 (−0.09, 2.31) −0.36 (−0.82, 0.10)
Oral cavity 1.47 (0.24, 2.71) −0.37 (−0.72, −0.02)
Left submandibular gland 1.71 (0.14, 3.27) −0.94 (−1.59, −0.28)
Right submandibular gland 1.74 (0.45, 3.04) −0.98 (−1.57, −0.39)
Larynx 2.28 (1.09, 3.47) −0.97 (−1.57, −0.38)
Mandible 1.11 (0.20, 2.02) −1.60 (−2.39, −0.81)
PTV1 2.29 (1.00, 3.59) −0.48 (−1.83, 0.88)
PTV2 2.18 (−1.19, 5.55) −0.15 (−0.68, 0.37)
PTV3 1.55 (−0.03, 3.14) −0.32 (−0.74, 0.10)
Left parotid 0.49 (−0.61, 1.60) −0.95 (−1.33, −0.57)
Right parotid 0.43 (−0.63, 1.49) −0.93 (−1.20, −0.66)
Cervix
Left femoral head −1.78 (−2.78, −0.77) 0.21 (−0.92, 1.34)
Right femoral head −1.79 (−2.81, −0.77) 0.19 (−0.93, 1.31)
L4 −2.21 (−4.87, 0.45) 0.49 (−4.43, 5.41)
L5 −2.59 (−3.43, −1.74) 0.48 (−1.31, 2.27)
Chest wall
Clinical chest wall 1.51 (−1.65, 4.67) −1.55 (−3.62, 0.52)
Clavicle −0.86 (−2.20, 0.49) −3.60 (−5.64, −1.56)
Heart −0.17 (−0.68, 0.35) −0.10 (−0.68, 0.49)
Humeral head −0.34 (−1.18, 0.50) −0.52 (−1.01, −0.03)
Left lung −0.40 (−1.66, 0.86) −0.36 (−1.97, 1.25)
Right lung −0.34 (−1.69, 1.02) −0.32 (−1.79, 1.15)
Ribcage −0.17 (−1.05, 0.71) −1.99 (3.59, −0.39)
Supraclavical 0.23 (−1.33, 1.78) −1.21 (−2.69, 0.28)
Spinal canal −0.17 (−0.51, 0.17) −0.14 (−0.35, 0.07)
Sternum 0.61 (−0.56, 1.78) −0.48 (−1.53, 0.57)

Abbreviations: CCC, collapsed cone convolution; CTV, clinical target volume; LCL, lower control limit; PTV, planning target volume; RPA, Radiation Planning Assistant; UCL, upper control limit.

a

All values are percentages.